Search clinical trials for: Colitis, Ulcerative

Total 1550 results

University of British Columbia

Active, not recruiting

The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis

Ulcerative Colitis

Canada
Kelly Boone
Children's Hospital Medical Center, Cincinnati

Terminated

Peer Mentoring to Improve Self-management in Youth With IBD

Inflammatory Bowel Diseases | Pediatric Ulcerative Colitis | Pediatric Crohns Disease

United States
Zagazig University

Completed

Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients

Inflammatory Bowel Diseases | Hemorrhoids | Anal Fissure

Egypt
University of Texas at Austin

Suspended

Diet Patterns in IBD in Central Texas

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

United States
Takeda
Takeda Development Center Americas, Inc.

Active, not recruiting

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Crohn's Disease | Ulcerative Colitis

Israel, United States, Hungary, Belgium, France, Poland, Ukraine, United Kingdom
University of British Columbia

Active, not recruiting

Pro-active Fecal Calprotectin Monitoring PROMOTE-UC

Ulcerative Colitis

Canada
Takeda

Active, not recruiting

A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

Crohn's Disease | Colitis, Ulcerative

United States, Belgium, Israel, Spain, Korea, Republic of, Taiwan, Netherlands, Australia, Denmark, Hungary, Italy, Russian Federation, Brazil, Croatia, Germany, Serbia, Bulgaria, Canada, Poland, Slovakia, Ukraine, Czechia, Argentina, Turke... and more
Alimentiv Inc.

Active, not recruiting

Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis (PROTOS)

Ulcerative Colitis

United States, Canada
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)

Moderate to Severe Ulcerative Colitis

United States, China, Pakistan, Ukraine
Oslo University Hospital
Helse Sor-Ost

Completed

Boosting Biologics in UC

Inflammatory Bowel Diseases | Ulcerative Colitis

Norway
Catherine Bollard

Completed

Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease

Inflammatory Bowel Diseases

United States
Athos Therapeutics Inc
Syneos Health; Athos Therapeutics Australia Pty Ltd

Completed

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects

Autoimmune Diseases | Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Australia
MuReva Phototherapy Inc.

Active, not recruiting

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

Head and Neck Cancer | Oral Mucositis (Ulcerative) | Oral Mucositis (Ulcerative) Due to Radiation | Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy

United States
Belgian Inflammatory Bowel Disease Research and...
Celltrion

Active, not recruiting

Subcutaneous Infliximab After A Previous Intravenous Dose Optimization (AMARETTO)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Belgium
Kyowa Kirin, Inc.

Completed

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

Digestive System Diseases | Gastrointestinal Diseases | Colonic Diseases | Intestinal Diseases | Abdominal Pain | Inflammatory Bowel Diseases | Ulcerative Colitis | Colitis | Colitis, Ulcerative | Autoimmune Disease

Hungary, Russian Federation, Serbia, United States, Poland, Czechia, Romania
Zuyderland Medisch Centrum

Enrolling by invitation

Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease (SHUFFLE)

Crohn Disease | Ulcerative Colitis | IBD | Infliximab

Netherlands
Joshua Korzenik

Withdrawn

Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative Colitis Remission (HARBOUR)

Ulcerative Colitis

United States
Bristol-Myers Squibb

Terminated

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Colitis, Ulcerative

United States, Australia, Canada, Germany, Poland, Puerto Rico, United Kingdom, Netherlands
Sanguine Biosciences

Completed

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Depression | Melanoma | Epilepsy | Lymphoma | Multiple Sclerosis | Kidney Cancer | Cervical Cancer | Diabetes Mellitus | Leukemia | Breast Cancer | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Parkinson's Disease | Systemic Lupus Erythematosus | Multiple Myeloma | Hepatitis B | Insomnia | Colorectal Cancer | HIV/AID... and other conditions

United States
Takeda

Active, not recruiting

A Study of Vedolizumab in Adults in Real-World Practice

Crohn Disease | Colitis, Ulcerative

China
Stefan Holubar MD MS FACS, FASCRS

Withdrawn

SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery (SAVES-IBD)

Crohn Disease | Ulcerative Colitis | Venous Thromboembolism

United States
The Hospital for Sick Children
The Leona M. and Harry B. Helmsley Charitable Trust; Crohn's and Colitis Canada and other collaborators

Active, not recruiting

Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | Mental Health Wellness 1 | Adolescent Development | Transition

Canada
Takeda

Completed

A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)

Inflammatory Bowel Diseases | Colitis, Ulcerative | Crohns Disease

Croatia, Slovenia
University Medical Center Groningen

Completed

Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patients (VISION)

Crohn Disease | Colitis, Ulcerative

Netherlands
Tata Memorial Centre

Completed

Ability of Curcumin to Decrease Cytokines Involved in Mucositis in the Autologous Transplant

Oral Mucositis (Ulcerative)

India
Pfizer

Active, not recruiting

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

Ulcerative Colitis

United States, Poland, Germany
The Hospital for Sick Children
MOUNT SINAI HOSPITAL; Crohn's and Colitis Foundation

Active, not recruiting

Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis | Healthy Controls

Canada
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Terminated

Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy (CYTOVEDO)

Ulcerative Colitis, Unspecified

France
CannaMore Biotechs

Active, not recruiting

Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients

Ulcerative Colitis

Israel
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Active, not recruiting

Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis (GLADIATOR UC)

Ulcerative Colitis

United States, Israel, Spain, Korea, Republic of, Poland, Australia, Canada, Germany, Belarus, Russian Federation, Belgium, Czechia, Hungary, Georgia, Bulgaria, France, Italy, Portugal, Ukraine
Pfizer

Completed

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

Arthritis, Rheumatoid | Psoriasis | Crohn Disease | Colitis, Ulcerative

Japan
Takeda

Completed

A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice (INTENT)

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

Russian Federation, Belarus, Kazakhstan
Amgen

Completed

Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

Inflammatory Diseases

United Kingdom
Takeda

Completed

A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease

Crohn Disease | Ulcerative Colitis

India
Eli Lilly and Company

Completed

A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) (SHINE-1)

Ulcerative Colitis

United States, Canada, Israel, Korea, Republic of, Japan
Paris IBD Center

Completed

Bowel Urgency in Inflammatory Bowel Disease (URGENT-1)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

France
Ardahan University

Completed

Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative Colitis

Ulcerative Colitis

Turkey
Belgian Inflammatory Bowel Disease Research and...
Ferring Pharmaceuticals

Completed

ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA (CARUC-ASA)

Ulcerative Colitis

Belgium
University of Minnesota

Completed

Low Sulfur Fecal Transplant for Ulcerative Colitis

Ulcerative Colitis

United States
Takeda

Completed

Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes (VEDO TDM RWE)

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

Canada
Central Hospital, Nancy, France

Completed

Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients (MICI-METHO)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

France
Mayo Clinic

Enrolling by invitation

Mayo Clinic IBD Biobank

Inflammatory Bowel Diseases

United States
Massachusetts General Hospital

Active, not recruiting

Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis

Crohn's Disease

United States
Nantes University Hospital

Completed

Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic (IBD-COVID-19)

COVID | IBD

France
Bristol-Myers Squibb

Completed

Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Korea, Republic of, United States, Australia, Hungary, Germany, Italy, United Kingdom, Czechia, Japan, Russian Federation, France, Belgium, Poland
Immunic AG

Terminated

Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1)

Ulcerative Colitis

United States, Russian Federation, Serbia, Belarus, Netherlands, Spain, United Kingdom, Croatia, Poland, Albania, Bosnia and Herzegovina, Bulgaria, Czechia, Georgia, North Macedonia, Portugal, Romania, Turkey, Ukraine
Laboratorios Richmond S.A.C.I.F.
FP Clinical Pharma S.R.L.; Custom Biologics

Completed

A Clinical Study With Adalimumab Biosimilar

Pharmacokinetics | Safety Issues

Argentina
Icahn School of Medicine at Mount Sinai
Crohn's and Colitis Foundation

Active, not recruiting

Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis

Ulcerative Colitis (Disorder)

United States
Tianjin Hemay Pharmaceutical Co., Ltd

Terminated

Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

Ulcerative Colitis

China
Pfizer

Completed

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Crohn's Disease | Ulcerative Colitis

Japan

Search clinical trials for: Colitis, Ulcerative

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations